Biogen (BIIB) operating expenses was $7.1B in FY2020 (+32% YoY). The tables below show the complete quarterly and annual operating expenses history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Expenses
Fiscal Year
Operating Expenses
YoY
2020
$7.1B
+32%
2019
$5.4B
-6%
2018
$5.7B
+8%
2017
$5.3B
+11%
2016
$4.8B
+5%
2015
$4.5B
-0%
2014
$4.6B
+28%
2013
$3.6B
+14%
2012
$3.1B
+10%
2011
$2.8B
-5%
2010
$3.0B
+11%
2009
$2.7B
Recent Quarterly Operating Expenses
Quarter
Operating Expenses
Q1 2026
$1.1B
Q4 2025
$1.2B
Q3 2025
$1.0B
Q2 2025
$983M
Q1 2025
$1.0B
Q4 2024
$1.2B
Q3 2024
$1.1B
Q2 2024
$1.1B
Q1 2024
$1.0B
Q4 2023
$1.2B
Q3 2023
$1.5B
Q2 2023
$1.1B
Source: BIIB on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.